HEALTHPEAK PROPERTIES, INC. - FORM 8-K - EX-99.2

Attached files

file	filename
EX-99.1 - EX-99.1 - HEALTHPEAK PROPERTIES, INC.	a12-17229_1ex99d1.htm
8-K - 8-K - HEALTHPEAK PROPERTIES, INC.	a12-17229_18k.htm

Exhibit 99.2

Supplemental Information

June 30, 2012

(Unaudited)

Table of Contents

Company Information	1
Summary	2
Funds From Operations	3
Funds Available for Distribution	4
Capitalization	5
Credit Profile	6-7
Indebtedness and Ratios	8
Investments and Dispositions	9
Development	10
Owned Portfolio
Portfolio summary	12
Portfolio concentrations	13
Same property portfolio	14
Lease expirations and debt investment maturities	15
Owned Senior Housing Portfolio
Investments and operator concentration	16
Trends	17
Owned Post-Acute/Skilled Nursing Portfolio
Investments and operator concentration	18
Trends and HCR ManorCare information	19
Owned Life Science Portfolio
Investments, tenant concentration and trends	20
Selected lease expirations and leasing activity	21
Owned Medical Office Portfolio
Investments and trends	22
Leasing activity	23
Owned Hospital Portfolio
Investments and operator concentration	24
Trends	25
Investment Management Platform	26
Reporting Definitions and Reconciliations of Non-GAAP Measures	27-32

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this supplemental information which are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include among other things the Company’s estimate of (i) completion dates, stabilization dates, rentable square feet and total investment for development projects in progress, and (ii) rentable square feet for land held for development. These statements are made as of the date hereof, are not guarantees of future performance and are subject to known and unknown risks, uncertainties, assumptions and other factors—many of which are out of the Company and its management’s control and difficult to forecast—that could cause actual results to differ materially from those set forth in or implied by such forward-looking statements. These risks and uncertainties include but are not limited to: national and local economic conditions; continued volatility in the capital markets, including changes in interest rates and the availability and cost of capital, which changes and volatility affect opportunities for profitable investments; the Company’s ability to access external sources of capital when desired and on reasonable terms; the Company’s ability to manage its indebtedness levels; changes in the terms of the Company’s indebtedness; the Company’s ability to maintain its credit ratings; the potential impact of existing and future litigation matters, including the possibility of larger than expected litigation costs and related developments; the Company’s ability to successfully integrate the operations of acquired companies; risks associated with the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition and continued cooperation; competition for lessees and mortgagors (including new leases and mortgages and the renewal or rollover of existing leases); the Company’s ability to reposition its properties on the same or better terms if existing leases are not renewed or the Company exercises its right to replace an existing operator or tenant upon default; continuing reimbursement uncertainty in the post-acute/skilled nursing segment; competition in the senior housing segment specifically and in the healthcare industry in general; the ability of the Company’s operators and tenants from its senior housing segment to maintain or increase their occupancy levels and revenues; the ability of the Company’s lessees and mortgagors to maintain the financial strength and liquidity necessary to satisfy their respective obligations to the Company and other third parties; the bankruptcy, insolvency or financial deterioration of the Company’s operators, lessees, borrowers or other obligors; changes in healthcare laws and regulations, including the impact of future or pending healthcare reform, and other changes in the healthcare industry which affect the operations of the Company’s lessees or obligors, including changes in the federal budget resulting in the reduction or nonpayment of Medicare or Medicaid reimbursement rates; the Company’s ability to recruit and retain key management personnel; costs of compliance with regulations and environmental laws affecting the Company’s properties; changes in tax laws and regulations; changes in the financial position or business strategies of HCR ManorCare; the Company’s ability and willingness to maintain its qualification as a REIT due to economic, market, legal, tax or other considerations; changes in rules governing financial reporting, including new accounting pronouncements; and other risks described from time to time in the Company’s Securities and Exchange Commission filings. The Company assumes no, and hereby disclaims any, obligation to update any of the foregoing or any other forward-looking statements as a result of new information or new or future developments, except as otherwise required by law.

Company Information(1)

Board of Directors

James F. Flaherty III	Michael D. McKee
Chairman and Chief Executive Officer	Chief Executive Officer
HCP, Inc.	Bentall Kennedy U.S., L.P.

Christine N. Garvey	Peter L. Rhein
Former Global Head of Corporate	Partner, Sarlot & Rhein
Real Estate Services, Deutsche Bank AG

David B. Henry	Kenneth B. Roath
Vice Chairman, President and Chief	Chairman Emeritus, HCP, Inc.
Executive Officer, Kimco Realty Corporation

Lauralee E. Martin	Joseph P. Sullivan
Chief Operating and Financial Officer	Chairman Emeritus of the Board of Advisors
Jones Lang LaSalle Incorporated	RAND Health


Senior Management

James F. Flaherty III	Thomas M. Klaritch
Chairman and	Executive Vice President
Chief Executive Officer	Medical Office Properties

Jonathan M. Bergschneider	James W. Mercer
Executive Vice President	Executive Vice President, General Counsel
Life Science Estates	and Corporate Secretary

Paul F. Gallagher	Timothy M. Schoen
Executive Vice President and	Executive Vice President and
Chief Investment Officer	Chief Financial Officer

Edward J. Henning	Susan M. Tate
Executive Vice President	Executive Vice President
	Post-Acute and Hospitals
Thomas D. Kirby
Executive Vice President	Kendall K. Young
Acquisitions and Valuations	Executive Vice President
	Senior Housing

Other Information

Corporate Headquarters	San Francisco Office
3760 Kilroy Airport Way, Suite 300	400 Oyster Point Boulevard, Suite 409
Long Beach, CA 90806-2473	South San Francisco, CA 94080
(562) 733-5100

Nashville Office
3000 Meridian Boulevard, Suite 200
Franklin, TN 37067

The information in this supplemental information package should be read in conjunction with the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other information filed with the Securities and Exchange Commission (“SEC”). The Reporting Definitions and Reconciliations of Non-GAAP Measures are an integral part of the information presented herein.

On the Company’s internet website, www.hcpi.com, you can access, free of charge, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information contained on its website is not incorporated by reference into, and should not be considered a part of, this supplemental information package. In addition, the SEC maintains an internet website that contains reports, proxy and information statements, and other information regarding issuers, including HCP, that file electronically with the SEC at www.sec.gov.

For more information, contact Timothy M. Schoen, Executive Vice President and Chief Financial Officer at (562) 733-5309.

(1) As of July 27, 2012.

Summary

Dollars in thousands, except per share data

	Three Months Ended June 30,				Six Months Ended June 30,
	2012		2011		2012		2011
Revenues	$	464,439	$	488,125	$	923,450	$	819,253

NOI	392,666		380,480		783,016		626,060

Adjusted (Cash) NOI	357,913		339,830		712,017		562,940

YoY SPP Adjusted (Cash) NOI % Change	3.1%		2.6%		3.9%		4.7%

Adjusted EBITDA	$	399,116	$	432,365	$	790,062	$	701,834

Diluted FFO per common share	0.69		0.78		1.34		1.19

Diluted FFO as adjusted per common share	0.69		0.77		1.36		1.35

Diluted FAD per common share	0.56		0.62		1.10		1.12

Diluted EPS	0.48		0.55		0.90		0.73

Dividends declared per common share	0.50		0.48		1.00		0.96

FFO as adjusted payout ratio	72%		62%		74%		71%

FAD payout ratio	89%		77%		91%		86%

Financial leverage					39.5%		39.9%

Adjusted fixed charge coverage					3.4x		2.9x

	June 30,		December 31,
Total properties:	2012		2011
Senior housing	314		314

Post-acute/skilled nursing	313		313

Life science	113		108

Medical office	251		254

Hospital	21		21

Total	1,012		1,010

Portfolio Income from

Assets Under Management(1)

Assets Under

Management: $19.1 billion(2)

(1) Represents adjusted NOI from real estate owned by HCP, interest income from debt investments and HCP’s pro rata share of adjusted NOI from real estate owned by the Company’s Investment Management Platform, excluding assets under development and land held for development, for the six months ended June 30, 2012.

(2) Represents the historical cost of real estate owned by HCP, the carrying amount of debt investments and 100% of the cost of real estate owned by the Company’s Investment Management Platform, excluding assets held for sale and under development and land held for development, at June 30, 2012.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Funds From Operations

Dollars and shares in thousands, except per share data

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Net income applicable to common shares	$	201,467		$	222,993		$	376,724		$	286,939
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	87,924			89,814			176,165			180,996
Discontinued operations	—			238			35			476
DFL depreciation	3,142			2,633			6,192			3,005
Gain on sales of real estate	—			—			(2,856		)	—
Gain upon consolidation of joint venture	—			270			—			(7,769		)
Equity income from unconsolidated joint ventures	(15,732		)	(14,950		)	(29,407		)	(15,748		)
FFO from unconsolidated joint ventures	18,275			17,519			34,452			20,834
Noncontrolling interests’ and participating securities’ share in earnings	3,508			5,976			7,809			10,731
Noncontrolling interests’ and participating securities’ share in FFO	(4,963		)	(6,582		)	(10,691		)	(11,806		)
FFO applicable to common shares	$	293,621		$	317,911		$	558,423		$	467,658
Distributions on dilutive convertible units	3,127			2,964			6,249			6,018
Diluted FFO applicable to common shares	$	296,748		$	320,875		$	564,672		$	473,676

Weighted average shares used for diluted FFO per share	427,496			413,996			422,507			397,060

Diluted FFO per common share	$	0.69		$	0.78		$	1.34		$	1.19

Dividends declared per common share	$	0.50		$	0.48		$	1.00		$	0.96

FFO payout ratio	72.5%			61.5%			74.6%			80.7%

Impact of adjustments to FFO:
Preferred stock redemption charge(1)	$	—		$	—		$	10,432		$	—
Merger-related items(2)	—			(5,712		)	—			26,596
	$	—		$	(5,712	)	$	10,432		$	26,596

FFO as adjusted applicable to common shares	$	293,621		$	312,199		$	568,855		$	494,254
Distributions on dilutive convertible units and other	3,127			2,975			6,218			5,915
Diluted FFO as adjusted applicable to common shares	$	296,748		$	315,174		$	575,073		$	500,169

Weighted average shares used for diluted FFO as adjusted per share	427,496			408,985			422,507			371,004		(3)

Diluted FFO as adjusted per common share	$	0.69		$	0.77		$	1.36		$	1.35	(3)

FFO as adjusted payout ratio	72.5%			62.3%			73.5%			71.1%

(1) In connection with the redemption of the Company’s preferred stock, during the six months ended June 30, 2012, the Company incurred a one-time, non-cash redemption charge of $10.4 million, or $0.02 per share, related to the original issuance costs.

(2) Merger-related items for the six months ended June 30, 2011 are attributable to the HCR ManorCare Acquisition (incurred from January 1st through April 6th 2011), which include the following: (i) $26.8 million of direct transaction costs, (ii) $23.9 million of interest expense associated with the $2.4 billion senior unsecured notes offering completed on January 24, 2011, which proceeds were obtained to prefund the HCR ManorCare Acquisition, partially offset by (iii) $24.1 million of income related to gains upon the reinvestment of the Company’s debt investment in HCR ManorCare and other miscellaneous items.

(3) $0.16 per share of merger-related items attributable to the HCR ManorCare Acquisition include the following:

(i) $0.07 per share of direct transaction costs that is discussed in footnote 2(i);

(ii) ($0.07) per share of income related to gains upon the reinvestment of the Company’s debt investment in HCR ManorCare debt and other miscellaneous items that are discussed in footnote 2(iii); and

(iii) $0.16 per share of negative carry related to prefunding activities of: (a) $0.09 per share from the Company’s December 2010 46 million share common stock offering and 30 million shares from the Company’s March 2011 common stock offering (excludes 4.5 million shares sold to the underwriters upon exercise of their option to purchase additional shares), which issuances increased weighted average shares by 26 million for the six months ended June 30, 2011; and (b) $0.07 per share for additional interest expense related to the $2.4 billion senior unsecured notes offering that is discussed in footnote 2(ii). Proceeds from these offerings were used to prefund a portion of the cash consideration for the HCR ManorCare Acquisition.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Funds Available for Distribution

Dollars and shares in thousands, except per share data

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
FFO as adjusted applicable to common shares	$	293,621		$	312,199		$	568,855		$	494,254
Amortization of above and below market lease intangibles, net	(625		)	(1,187		)	(1,322		)	(2,093		)
Amortization of deferred compensation	6,034			5,103			11,407			10,205
Amortization of deferred financing costs, net	3,930			3,391			8,459			6,349
Straight-line rents	(11,860		)	(15,612		)	(21,787		)	(32,912		)
DFL accretion(1)	(22,017		)	(22,262		)	(47,639		)	(24,937		)
DFL depreciation	(3,141		)	(2,633		)	(6,191		)	(3,005		)
Deferred revenues – tenant improvement related	(346		)	(767		)	(833		)	(1,643		)
Deferred revenues – additional rents (SAB 104)	(324		)	(1,416		)	2,002			566
Leasing costs and tenant and capital improvements	(18,181		)	(11,447		)	(27,112		)	(20,940		)
Joint venture and other FAD adjustments(1)	(12,240		)	(13,494		)	(26,665		)	(14,347		)
FAD applicable to common shares	$	234,851		$	251,875		$	459,174		$	411,497
Distributions on convertible units	1,791			2,964			3,577			2,616
Diluted FAD applicable to common shares	$	236,642		$	254,839		$	462,751		$	414,113

Weighted average shares used for diluted FAD per share	425,238			408,985			420,236			368,704

Diluted FAD per common share	$	0.56		$	0.62		$	1.10		$	1.12

Dividends declared per common share	$	0.50		$	0.48		$	1.00		$	0.96

FAD payout ratio	89.3%			77.4%			90.9%			85.7%

(1) For the three and six months ended June 30, 2012, DFL accretion reflects an elimination of $14.8 million and $29.5 million, respectively. For both the three and six months ended June 30, 2011, DFL accretion reflects an elimination of $13.3 million. The Company’s ownership interest in HCR ManorCare OpCo is accounted for using the equity method, which requires an ongoing elimination of DFL income that is proportional to the Company’s ownership in HCR ManorCare OpCo. Further, the Company’s share of earnings from HCR ManorCare OpCo (equity income) increases for the corresponding elimination of related lease expense recognized at the HCR ManorCare OpCo level, which is presented as a non-cash joint venture FAD adjustment.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Capitalization

Dollars and shares in thousands, except price data

*Total Debt*
	June 30, 2012		December 31, 2011		June 30, 2011
Bank line of credit(1)	$	215,015	$	454,000	$	—
Senior unsecured notes	5,615,979			5,416,063		5,706,998
Mortgage debt	1,726,944			1,764,571		1,780,665
Other debt	84,060			87,985		89,466
Consolidated debt	7,641,998			7,722,619		7,577,129
HCP’s share of unconsolidated debt(2)	142,200			143,196		144,620
Total debt	$	7,784,198	$	7,865,815	$	7,721,749

*Total Market Capitalization*
	June 30, 2012
	Shares		Value		Total Value
Common stock (NYSE: HCP)	429,402		$	44.15	$	18,958,098

Convertible partnerships (DownREITs)(3)	5,825		44.15		257,174

Total market equity					$	19,215,272

Consolidated debt					7,641,998

Total market equity and consolidated debt					$	26,857,270

HCP’s share of unconsolidated debt(2)					142,200

Total market capitalization					$	26,999,470

*Common Stock and Equivalents*
		Weighted Average Shares
	Shares	Three Months Ended June 30, 2012
	Outstanding	Diluted	Diluted	Diluted FFO	Diluted
	June 30, 2012	EPS	FFO	As Adjusted	FAD
Common stock	429,402	420,468	420,468	420,468	420,468
Common equivalent securities:
Restricted stock and units	1,773	270	270	270	270
Dilutive impact of options	933	933	933	933	933
Convertible partnership units	5,825	—	5,825	5,825	3,567
Total common and equivalents	437,933	421,671	427,496	427,496	425,238

		Weighted Average Shares
		Six Months Ended June 30, 2012
		Diluted	Diluted	Diluted FFO	Diluted
		EPS	FFO	As Adjusted	FAD
Common stock		415,243	415,243	415,243	415,243
Common equivalent securities:
Restricted stock and units		256	256	256	256
Dilutive impact of options		1,167	1,167	1,167	1,167
Convertible partnership units		—	5,841	5,841	3,570
Total common and equivalents		416,666	422,507	422,507	420,236

(1) The amount outstanding under the Company’s bank line of credit as of June 30, 2012 represents a draw of £137 million that is translated into U.S. dollars.

(2) Reflects the Company’s pro rata share of amounts in the Investment Management Platform and HCR ManorCare OpCo.

(3) Convertible partnership (DownREIT) units are exchangeable for an amount of cash approximating the then-current market value of shares of the Company’s common stock at the time of conversion or, at the Company’s election, shares of the Company’s common stock.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Credit Profile

Financial Leverage

Secured Debt Ratio

Adjusted Fixed Charge Coverage

Net Debt to Adjusted EBITDA

Credit Ratings (Senior Unsecured Debt)

Pre-CNL(1)
Acquisition

2006

2007

2008

2009

2010

2011

2012

Moody’s

Baa2

Baa3

Baa2

Baa2 (Stable)

Standard & Poor’s

BBB+

BBB

BBB (Positive)

Fitch

BBB+

BBB

BBB+

BBB+ (Stable)

(1) As of and for the six months ended June 30, 2006 (12 months for adjusted fixed charge coverage). The Company completed the mergers with CNL Retirement Properties, Inc. and CNL Retirement Corp (“CNL”) on October 5, 2006, with significant prefunding activities occurring in the quarter ended September 30, 2006; therefore, the Company refers to the period ended June 30, 2006 as “Pre-CNL Acquisition.”

(2) Financial leverage, secured debt ratio and net debt to adjusted EBITDA are pro forma to exclude the temporary benefit resulting from prefunding the HCR ManorCare acquisition in December 2010.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Credit Profile

Same Property NOI Growth

Total Gross Assets

(In billions)

Liquidity(5)

(In billions)

Credit Ratings (Senior Unsecured Debt)

Pre-CNL(3)
Acquisition

2006

2007

2008

2009

2010

2011

2012

Moody’s

Baa2

Baa3

Baa2

Baa2 (Stable)

Standard & Poor’s

BBB+

BBB

BBB (Positive)

Fitch

BBB+

BBB

BBB+

BBB+ (Stable)

(1) HCP information represents annual SPP cash NOI growth except for 2Q 2012, which is year-over-year three-month growth.

(2) Major Property Sectors information was compiled by Green Street Advisors and is available in their Commercial Property Outlook report dated June 19, 2012 (the “Green Street Report”); this information represents the average annual same property NOI growth equally weighted for each of five major property sectors: apartment, industrial, mall, office, and strip center. The Company’s definitions of SPP and NOI may not be comparable to the measures compiled in the Green Street Report, as different methodologies may be used to define or calculate inputs to the growth rates presented.

(3) As of and for the six months ended June 30, 2006. The Company completed the mergers with CNL Retirement Properties, Inc. and CNL Retirement Corp (“CNL”) on October 5, 2006, with significant prefunding activities occurring in the quarter ended September 30, 2006; therefore, the Company refers to the period ended June 30, 2006 as “Pre-CNL Acquisition.”

(4) Total gross assets and liquidity are pro forma to exclude the temporary benefit resulting from prefunding the HCR ManorCare acquisition in December 2010.

(5) Represents the availability under the Company’s bank line of credit and cash and cash equivalents (unrestricted cash).

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Indebtedness and Ratios

Dollars in thousands

*Debt Maturities and Scheduled Principal Repayments (Amortization)*
*June 30, 2012*
			Senior													HCP’s Share of
	Bank Line		Unsecured					Mortgage					Consolidated			Unconsolidated
	of Credit(1)		Notes			Rates(2)		Debt(3)			Rates(2)		Debt			Debt(4)			Rates(2)		Total Debt
2012 (6 months)	$	—	$	—		—	%	$	28,148		6.02	%	$	28,148		$	1,332		N/A	%	$	29,480
2013	—		550,000			5.80		367,374			6.04		917,374			3,271			7.04		920,645
2014	—		487,000			3.23		183,758			5.76		670,758			849			N/A		671,607
2015	—		400,000			6.64		302,102			6.02		702,102			11,347			5.82		713,449
2016	215,015		900,000			5.07		285,586			6.91		1,400,601			47,057			6.05		1,447,658
2017	—		750,000			6.04		512,460			6.10		1,262,460			41,376			5.86		1,303,836
2018	—		600,000			6.83		5,747			5.90		605,747			37,130			5.00		642,877
2019	—		450,000			3.95		1,184			N/A		451,184			—			—		451,184
2020	—		—			—		1,276			N/A		1,276			—			—		1,276
2021	—		1,200,000			5.53		4,242			5.58		1,204,242			—			—		1,204,242
Thereafter	—		300,000			6.89		47,778			5.17		347,778			—			—		347,778
Subtotal	215,015		5,637,000					1,739,655					7,591,670			142,362					7,734,032
Other debt(5)	—		—					—					84,060			—					84,060
(Discounts) and premiums, net	—		(21,021		)			(12,711		)			(33,732		)	(162		)			(33,894		)
Total debt	$	215,015	$	5,615,979				$	1,726,944				$	7,641,998		$	142,200				$	7,784,198

Weighted average interest rate	2.07%		5.51%					6.14%					5.56%			5.85%					5.56%

Weighted average maturity in years	3.70		6.17					3.93					5.58			4.61					5.57

*Ratios*			*Covenants*
	June 30,	December 31,	The following is a summary of the financial covenants under the revolving line of credit facility at June 30, 2012.
	2012	2011
Consolidated Debt/Consolidated Gross Assets	39.4%	41.0%
Financial Leverage (Total Debt/Total Gross Assets)	39.5%	41.0%		Bank Line of Credit
			Financial Covenants(6)	Requirement	Actual Compliance
Consolidated Secured Debt/Consolidated Gross Assets	8.9%	9.4%	Leverage Ratio	No greater than 60%	40%
Secured Debt Ratio (Total Secured Debt/Total Gross Assets)	9.5%	10.0%	Secured Debt Ratio	No greater than 30%	10%
			Unsecured Leverage Ratio	No greater than 60%	38%
Fixed and variable rate ratios(7):			Fixed Charge Coverage Ratio (12 months)	No less than 1.50x	3.12x
Fixed rate Total Debt	96.2%	93.1%
Variable rate Total Debt	3.8%	6.9%
	100.0%	100.0%

(1) The amount outstanding under the Company’s bank line of credit as of June 30, 2012 represents a draw of £137 million that is translated into U.S. dollars. This amount was repaid in full with proceeds from the Company’s £137 million four-year unsecured term loan which closed on July 30, 2012.

(2) Senior unsecured notes and mortgage debt weighted average effective rates relate to maturing amounts.

(3) Mortgage debt attributable to non-controlling interests at June 30, 2012 was $66 million.

(4) Includes pro-rata share of mortgage and other debt in the Company’s Investment Management Platform and HCR ManorCare OpCo. At June 30, 2012, 100% of the Company’s Investment Management Platform’s mortgage debt accrues interest at fixed rates. HCR ManorCare OpCo’s debt accrues interest at LIBOR (subject to a floor of 150bps) plus 350bps.

(5) Represents non-interest bearing life care bonds and occupancy fee deposits at certain of the Company’s senior housing facilities that have no scheduled maturities.

(6) Financial covenants for the revolving line of credit facility are calculated based on the definitions contained within the agreement and may be different than similar terms in the Company’s Consolidated Financial Statements as provided in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Compliance with certain of these financial covenants requires the inclusion of the Company’s consolidated amounts and its proportionate share of unconsolidated investees.

(7) $87 million of variable-rate mortgages are presented as fixed-rate debt as the interest payments under such debt have been swapped (pay fixed and receive float).

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Investments and Dispositions

Dollars and square feet in thousands
*Investments*
	June 30, 2012
Description	Three Months Ended		Six Months Ended
Purchase of marketable debt securities(1)	$	214,859	$	214,859
Acquisitions of real estate and land	11,050		11,050
Total fundings for development, tenant and capital improvements(2)	48,276		78,658
Construction loan commitment fundings	10,817		20,757
Total investments	$	285,002	$	325,324

Acquisitions of real estate and land for the six months ended June 30, 2012

Location

Date

Capacity

Property
Count

Segment

Investment

Durham, NC

May 15, 2012

115 sq. ft.

Life science

8,050

Slidell, LA

May 30, 2012

12.6 acres

—

Hospital

3,000

11,050

Dispositions for the six months ended June 30, 2012

Location

Date

Capacity

Property
Count

Segment

Investment

St. Louis, MO

February 29, 2012

44 sq. ft.

Medical office

6,982

(1) Senior unsecured notes of Four Seasons Health Care with an aggregate par value of £138.5 million, purchased at a discount for £136.8 million, and translated into U.S. dollars as of June 30, 2012.

(2) The three months ended June 30, 2012, includes the following: (i) $25.2 million of development, (ii) $8.3 million of first generation tenant and capital improvements, and (iii) $14.8 million of second generation tenant and capital improvements (excludes $3.4 million of leasing costs). The six months ended June 30, 2012, includes the following: (i) $44.8 million of development, (ii) $14.2 million of first generation tenant and capital improvements, and (iii) $19.7 million of second generation tenant and capital improvements (excludes $7.4 million of leasing costs).

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Development

As of June 30, 2012, dollars and square feet in thousands

Development Projects in Process

Estimated/

Estimated

Actual

Rentable

Estimated

Completion

Square

Investment

Total

Name of Project

Location

Segment

Date

Feet

to Date(1)(3)

Investment

Development

2019 Stierlin Ct.

Mountain View, CA

Life science

1Q 2013

7,416

22,233

Redevelopment

1030 Massachusetts Avenue

Cambridge, MA

Life science

3Q 2012

34,030

39,992

Durham Research Lab

Durham, NC

Life science

3Q 2013

11,670

24,586

Carmichael

Durham, NC

Life science

3Q 2013

3,038

16,380

Knoxville

Knoxville, TN

Medical office

4Q 2011

5,128

5,640

Westpark Plaza

Plano, TX

Medical office

1Q 2012

13,457

17,159

Innovation Drive

San Diego, CA

Medical office

3Q 2012

27,137

33,689

Alaska

Anchorage, AK

Medical office

3Q 2012

14,636

16,617

Conroe

Conroe, TX

Medical office

4Q 2012

5,366

9,316

Folsom

Sacramento, CA

Medical office

1Q 2013

31,230

39,251

Fresno

Fresno, CA

Hospital

1Q 2013

N/A

10,799

20,554

Total

163,907

245,417

*Land Held for Development*

					Estimated
			Gross		Rentable
			Site		Square
	Location	Segment	Acreage		Feet
	So. San Francisco, CA	Life science	50		1,666
	Carlsbad, CA	Life science	41		690
	Poway, CA	Life science	72		1,204
	Various	Various	19		93
			182

	Investment-to-date(2)(3)		$	390,886

Projects Placed in Service

Date

Rentable

Placed in

Square

Percentage

Name of Project

Location

Segment

Service

Feet

Investment(4)

Leased

Modular Labs IV

So. San Francisco, CA

Life science

January 2012

56,179

Soledad

San Diego, CA

Life science

February 2012

13,208

100

Knoxville(5)

Knoxville, TN

Medical office

June 2012

3,100

100

144

72,487

(1) Investment-to-date of $164 million includes the following: (i) $60 million in development costs and construction in progress, (ii) $85 million of buildings and (iii) $19 million of land.

(2) Investment-to-date of $391 million includes the following: (i) $289 million in land and (ii) $102 million in development costs and construction in progress.

(3) Development costs and construction in progress of $204 million presented on the Company’s consolidated balance sheet at June 30, 2012, include the following: (i) $60 million of costs for development projects in process; (ii) $102 million of costs for land held for development; and (iii) $42 million for tenant and other facility related improvement projects in process.

(4) Represents the investment as of the date the respective property was placed in service.

(5) Represents approximately 50% of the Knoxville facility placed in service in June 2012.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Portfolio Information

June 30, 2012

(Unaudited)

Owned Portfolio Summary

As of and for the six months ended June 30, 2012, dollars and square feet in thousands

*Portfolio Summary by Investment Product*

Leased	Property					Age			Occupancy	EBITDAR(1)			EBITDARM(1)
Properties	Count	Investment		NOI		(Years)	Capacity		%	Amount		CFC	Amount		CFC
Senior housing	293	$	5,167,649	$	232,206	15	31,148	Units	85.3	$	398,445	1.13 x	$	477,227	1.35 x
Post-acute/skilled	313	5,610,791		268,300		33	41,605	Beds	86.3	58,460		1.58 x	78,773		2.12 x
Life science	109	3,340,155		117,936		19	7,000	Sq. Ft.	89.6	N/A		N/A	N/A		N/A
Medical office	185	2,295,609		97,178		20	12,972	Sq. Ft.	91.4	N/A		N/A	N/A		N/A
Hospital	17	648,208		40,122		26	2,410	Beds	52.6	373,339		4.67 x	408,748		5.12 x
	917	$	17,062,412	$	755,742	23

Operating Properties (RIDEA)	Property Count	Investment		NOI		Age (Years)	Capacity		Occupancy %
Senior housing(2)	21	$	752,674	$	27,274	22	5,008	Units	86.5

Debt Investments		Investment		Interest Income
Senior housing		$	32,001	$	810
Post-acute/skilled(3)		224,477		707
Hospital(4)		83,903		518
		$	340,381	$	2,035
Total	938	$	18,155,467	$	785,051

*Portfolio NOI, Adjusted NOI and Interest Income*

	Three Months Ended June 30, 2012
	Rental and										Adjusted NOI
	RIDEA		Operating				Adjusted		Interest		and Interest
Segment	Revenues		Expenses		NOI(5)		NOI		Income		Income
Senior housing(2)	$	152,014	$	23,444	$	128,570	$	116,509	$	527	$	117,036
Post-acute/skilled	134,677		172		134,505		116,833		427		117,260
Life science	72,545		13,555		58,990		55,735		—		55,735
Medical office	80,905		31,979		48,926		47,682		—		47,682
Hospital	22,612		937		21,675		21,154		262		21,416
	$	462,753	$	70,087	$	392,666	$	357,913	$	1,216	$	359,129

	Six Months Ended June 30, 2012
	Rental and										Adjusted NOI
	RIDEA		Operating				Adjusted		Interest		and Interest
Segment	Revenues		Expenses		NOI(5)		NOI		Income		Income
Senior housing(2)	$	304,554	$	45,074	$	259,480	$	233,527	$	810	$	234,337
Post-acute/skilled	268,672		372		268,300		230,002		707		230,709
Life science	144,375		26,439		117,936		114,838		—		114,838
Medical office	160,861		63,683		97,178		94,604		—		94,604
Hospital	41,990		1,868		40,122		39,046		518		39,564
	$	920,452	$	137,436	$	783,016	$	712,017	$	2,035	$	714,052

(1) EBITDAR, EBITDARM and their respective CFC are not presented for the disaggregated HCR ManorCare senior housing and post-acute/skilled nursing portfolios as the combined portfolio is cross-collateralized under a single master lease. See HCR ManorCare Leased Portfolio Summary on page 19 of this report.

(2) Brookdale Senior Living manages 21 assets on behalf of the Company under a RIDEA structure. For the three months ended June 30, 2012, revenues and operating expenses were $35.6 million and $22.7 million, respectively. For the six months ended June 30, 2012, revenues and operating expenses were $70.7 million and $43.4 million, respectively.

(3) Includes senior unsecured notes of Four Seasons Health Care with an aggregate par value of £138.5 million, purchased at a discount for £136.8 million. The amount included above represents the carrying value translated into U.S. dollars as of June 30, 2012.

(4) Includes a senior secured loan to Delphis Operations, LP (“Delphis”) that was placed on non-accrual status effective January 1, 2011 with a carrying value of $69 million at June 30, 2012. For additional information regarding the senior secured loan to Delphis see Note 7 to the Consolidated Financial Statements for the six months ended June 30, 2012 included in the Company’s Quarterly Report on Form 10-Q filed with the SEC.

(5) NOI attributable to non-controlling interests for the three and six months ended June 30, 2012 was $2.3 million and $4.7 million, respectively.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Portfolio Concentrations

As of and for the six months ended June 30, 2012, dollars in thousands

Geographic Diversification of Properties

	Total	Senior		Post-Acute/		Life		Medical						% of
Investment by State	Properties	Housing		Skilled		Science		Office		Hospital		Total		Total

CA	153	$	647,883	$	268,215	$	3,214,877	$	214,481	$	128,545	$	4,474,001	25

TX	96	686,736		103,520		—		693,208		227,064		1,710,528		10

FL	95	832,549		537,530		—		155,214		62,450		1,587,743		9

PA	54	260,852		1,192,667		—		—		—		1,453,519		8

IL	51	504,005		692,025		—		13,481		—		1,209,511		7

OH	72	214,422		674,939		—		9,239		—		898,600		5

MI	38	176,207		570,695		—		—		—		746,902		4

MD	34	300,028		228,283		—		29,991		—		558,302		3

VA	29	319,964		174,154		—		42,730		—		536,848		3

NJ	21	377,577		98,268		—		—		—		475,845		3

Other	295	1,600,100		1,070,495		125,278		1,137,265		230,149		4,163,287		23

Total	938	$	5,920,323	$	5,610,791	$	3,340,155	$	2,295,609	$	648,208	$	17,815,086	100

	Total	Senior		Post-Acute/		Life		Medical						% of
NOI by State	Properties	Housing		Skilled		Science		Office		Hospital		Total		Total

CA	153	$	30,444	$	12,774	$	111,100	$	6,430	$	8,336	$	169,084	22

TX	96	32,231		4,276		—		26,599		13,048		76,154		10

FL	95	35,966		25,087		—		7,163		3,925		72,141		9

PA	54	10,608		56,917		—		—		—		67,525		9

IL	51	21,286		31,880		—		663		—		53,829		7

OH	72	9,435		33,451		—		317		—		43,203		6

MI	38	7,995		25,895		—		—		—		33,890		4

MD	34	12,809		10,788		—		1,339		—		24,936		3

VA	29	11,780		8,623		—		1,800		—		22,203		3

CO	26	8,551		3,838		—		7,981		709		21,079		3

Other	290	78,375		54,771		6,836		44,886		14,104		198,972		24

Total	938	$	259,480	$	268,300	$	117,936	$	97,178	$	40,122	$	783,016	100

Operator/Tenant Diversification

	Primary	Annualized Revenues(1)
Company	Segment	Amount		%

HCR ManorCare	Post-acute/skilled	$	489,038	32

Brookdale Senior Living	Senior housing	142,143		9

Emeritus Corporation	Senior housing	102,037		7

Sunrise Senior Living	Senior housing	86,572		6

HCA	Hospital	48,671		3

Amgen	Life science	42,247		3

Genentech	Life science	38,387		3

Four Seasons Health Care	Post-acute/skilled	26,647		2

Kindred	Post-acute/skilled	16,758		1

Capital Senior Living	Senior housing	16,106		1

Other		517,401		33

		$	1,526,007	100

(1) The most recent monthly base rent (including additional rent floors), cash income from direct financing leases and/or interest income annualized for 12 months. Annualized revenues for operating properties under a RIDEA structure are based on the most recent month’s NOI annualized for 12 months. For additional details regarding “annualized revenues,” see reporting definitions.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Same Property Portfolio

As of June 30, 2012, dollars and square feet in thousands

Three-Month SPP
			Senior		Post-Acute/		Life		Medical
	Total		Housing		Skilled		Science		Office		Hospital

Property count	574		227		45		101		185		16

Investment	$	10,682,297	$	4,334,034	$	246,711	$	3,207,732	$	2,285,357	$	608,463

Percent of property portfolio (by investment)	60.0%		73.2%		4.4%		96.0%		99.6%		93.9%

Capacity			26,195 Units		5,321 Beds		6,685 Sq. Ft.		12,921 Sq. Ft.		2,379 Beds

Year-Over-Year Three-Month SPP


Occupancy:

June 30, 2012			85.9%			84.7%			91.5%			91.4%		56.3%

June 30, 2011			85.9%			85.5%			90.4%			90.9%		56.2%

% change			—%			(0.8%		)	1.1%			0.5%		0.1%

NOI % change	0.1%		(1.5%		)	0.5%			(0.2%		)	2.5%		3.0%

Adjusted NOI:

June 30, 2012	$	224,802	$	89,442		$	9,426		$	56,409		$	48,967	$	20,558

June 30, 2011	$	218,047	$	87,620		$	9,219		$	53,796		$	47,555	$	19,857

Adjusted NOI % change	3.1%		2.1%			2.2%			4.9%			3.0%		3.5%

Sequential Three-Month SPP


Occupancy:

June 30, 2012			85.9%			84.7%			91.5%			91.4%		56.3%

March 31, 2012			85.8%			84.7%			91.1%			91.2%		51.7%

% change			0.1%			—%			0.4%			0.2%		4.6%

NOI % change	1.3%		(0.9%		)	(0.4%		)	(0.1%		)	1.6%		18.2%

Adjusted NOI:

June 30, 2012	$	224,802	$	89,442		$	9,426		$	56,409		$	48,967	$	20,558

March 31, 2012	$	223,556	$	88,875		$	9,401		$	59,851		$	48,120	$	17,309

Adjusted NOI % change	0.6%		0.6%			0.3%			(5.8%		)	1.8%		18.8%

Year-Over-Year Six-Month SPP
			Senior		Post-Acute/		Life		Medical
	Total		Housing		Skilled		Science		Office		Hospital

Property count	569		223		45		101		184		16

Investment	$	10,555,586	$	4,239,145	$	246,711	$	3,207,732	$	2,253,535	$	608,463

Percentage of property portfolio (by investment)	59.3%		71.6%		4.4%		96.0%		98.2%		93.9%

Capacity			25,634 Units		5,321 Beds		6,685 Sq. Ft.		12,788 Sq. Ft.		2,379 Beds

Year-Over-Year Six-Month SPP


Occupancy:

June 30, 2012				85.9%			84.7%			91.5%			91.3%		56.3%

June 30, 2011				85.7%			85.5%			90.4%			90.8%		56.2%

% change				0.2%			(0.8%		)	1.1%			0.5%		0.1%

NOI % change	(0.0%		)	(1.5%		)	1.0%			(0.4%		)	1.9%		3.1%

Adjusted NOI:

June 30, 2012	$	443,352		$	174,571		$	18,827		$	116,260		$	95,827	$	37,867

June 30, 2011	$	426,667		$	171,005		$	18,321		$	107,765		$	93,041	$	36,535

Adjusted NOI % change	3.9%			2.1%			2.8%			7.9%			3.0%		3.6%

See Reporting Definitions and Reconciliations of Non-GAAP Measures

*Owned Portfolio Lease Expirations and Debt Investment Maturities*


At June 30, 2012, dollars and square feet in thousands

			Expiration Year(1)
Segment	Total		2012(2)		2013		2014		2015		2016		2017		2018		2019		2020		2021		Thereafter

*Lease Expirations*

Senior housing(3):
Properties	293		—		—		5		1		17		12		49		12		33		16		148
Annualized revenues	$	419,533	$	—	$	—	$	4,997	$	204	$	24,983	$	20,220	$	96,310	$	15,521	$	51,741	$	17,404	$	188,153

Post-acute/skilled:
Properties	313		—		—		9		1		6		9		3		12		4		—		269
Annualized revenues	$	467,778	$	—	$	—	$	7,197	$	439	$	5,915	$	8,480	$	1,696	$	10,071	$	3,068	$	—	$	430,912

Life science:
Square feet	6,274		91		471		342		816		209		927		517		121		922		557		1,301
Annualized revenues	$	229,760	$	1,722	$	11,528	$	10,156	$	25,985	$	5,631	$	30,069	$	25,392	$	4,106	$	41,451	$	31,501	$	42,219

Medical office:
Square feet	11,859		973		1,847		1,641		1,406		1,202		1,022		1,026		718		842		392		790
Annualized revenues	$	257,231	$	22,875	$	35,547	$	37,123	$	31,775	$	24,807	$	22,432	$	20,720	$	14,992	$	19,520	$	9,776	$	17,664

Hospital:
Properties	17		—		1		3		—		—		2		—		5		—		1		5
Annualized revenues	$	67,366	$	—	$	2,611	$	16,018	$	—	$	—	$	4,706	$	—	$	6,970	$	—	$	1,650	$	35,411

Total annualized revenues	$	1,441,668	$	24,597	$	49,686	$	75,491	$	58,403	$	61,336	$	85,907	$	144,118	$	51,660	$	115,780	$	60,331	$	714,359

% of Total	100		2		3		5		4		4		6		10		4		8		4		50

*Debt Investment Maturities*

Senior housing:
Annualized revenues	$	2,535	$	—	$	—	$	—	$	—	$	2,253	$	282	$	—	$	—	$	—	$	—	$	—

Post-acute/skilled:
Annualized revenues	$	27,745	$	—	$	932	$	166	$	—	$	—	$	—	$	—	$	—	$	26,647	$	—	$	—

Hospital(4)
Annualized revenues	$	1,052	$	—	$	—	$	—	$	1,052	$	—	$	—	$	—	$	—	$	—	$	—	$	—

Total annualized revenues	$	31,332	$	—	$	932	$	166	$	1,052	$	2,253	$	282	$	—	$	—	$	26,647	$	—	$	—

(1) The most recent monthly base rent (including additional rent floors), cash income from direct financing leases and/or interest income annualized for 12 months. For additional details regarding “annualized revenues,” see reporting definitions.

(2) Includes month-to-month and holdover leases.

(3) Excludes $53.0 million related to 21 facilities operated under a RIDEA structure by Brookdale Senior Living.

(4) Effective January 1, 2011, a senior secured loan to Delphis was placed on non-accrual status. During the six months ended June 30, 2012, no revenues were recognized for this loan; consequently, no annualized revenue amounts for this loan are presented. For additional information regarding the senior secured loan to Delphis see Note 7 to the Consolidated Financial Statements for the quarter ended June 30, 2012 included in the Company’s Quarterly Report on Form 10-Q filed with the SEC.

See Reporting Definitions and Reconciliations of Non-GAAP Measures


	15

Owned Senior Housing Portfolio

As of and for the six months ended June 30, 2012, dollars in thousands

*Investments*

Operating	Property					Average		Occupancy	EBITDAR			EBITDARM
Leases	Count	Investment		NOI		Age (Years)	Units	%	Amount		CFC	Amount		CFC
Assisted living	162	$	2,477,861	$	113,957	14	14,615	85.2	$	225,575	1.12 x	$	269,087	1.34 x
Independent living	26	626,125		30,644		22	4,662	85.5	59,197		1.05 x	67,745		1.20 x
CCRCs	12	607,925		27,708		23	3,779	88.1	63,644		1.17 x	77,092		1.41 x
	200	$	3,711,911	$	172,309	15	23,056	85.7	$	348,416	1.12 x	$	413,924	1.33 x

Direct Financing	Property					Average		Occupancy	EBITDAR(1)			EBITDARM(1)
Leases	Count	Investment		NOI		Age (Years)	Units	%	Amount		CFC	Amount		CFC
Assisted living	27	$	622,123	$	24,725	15	3,139	85.6	$	50,029	1.21 x	$	63,303	1.53 x
HCR ManorCare(1)	66	833,615		35,172		16	4,953	82.9	N/A		N/A	N/A		N/A
	93	$	1,455,738	$	59,897	16	8,092	84.0

Leased Properties	293	$	5,167,649	$	232,206	15	31,148	85.3	$	398,445	1.13 x	$	477,227	1.35 x

Operating Properties (RIDEA)	Property Count	Investment		NOI		Average Age (Years)	Units	Occupancy %
Assisted living	3	$	23,566	$	1,245	22	213	83.5
Independent living	18	729,108		26,029		22	4,795	86.7
	21	$	752,674	$	27,274	22	5,008	86.5

Debt Investments		Investment		Interest Income
Assisted living(2)		$	32,001	$	810

Total	314	$	5,952,324	$	260,290		36,156	85.4

Operator Concentration(3)

						NOI and
	Properties		Investment			Interest Income				Occupancy	EBITDAR	EBITDARM
Operator	Count	% Pooled	Amount		%	Amount		%	Units	%	CFC(1)	CFC(1)
Brookdale Senior Living(4)	59	61	$	1,682,356	28	$	74,907	29	11,607	87.6	1.23 x	1.46 x
Sunrise Senior Living(5)	48	98	1,322,176		22	46,945		18	5,566	87.0	1.19 x	1.46 x
Emeritus Corporation	69	96	1,142,811		19	62,492		24	7,741	84.1	1.15 x	1.36 x
HCR ManorCare(1)	66	100	833,615		14	35,172		14	4,953	82.9	N/A	N/A
Harbor Retirement Associates	14	100	211,103		4	8,090		3	1,346	85.3	0.99 x	1.25 x
Aegis Senior Living	10	80	182,152		3	7,871		3	701	87.1	1.02 x	1.20 x
Other	48	94	578,111		10	24,813		9	4,242	85.6	0.99 x	1.16 x
	314	90	$	5,952,324	100	$	260,290	100	36,156	85.4	1.13 x	1.35 x

(2) During the quarter ended June 30, 2012, the Company funded $10.8 million related to construction financing commitments totaling $119 million to build six Class A assisted living facilities. For each of these facilities, the Company holds a one-time purchase option upon the earlier of stabilized occupancy or the fourth anniversary of the loan closing.

(3) Property count, units, occupancy and CFCs are presented for leased and operating properties, if applicable, and exclude debt investments.

(4) Occupancy for 35 assets (formerly operated by Horizon Bay Retirement Living prior to September 2011) and the CFC for 14 of these 35 assets are reported in “other” until the requisite periods have elapsed to allow the Company to report such measures completely under the new operator. CFC for the remaining 21 assets operated under a RIDEA structure is excluded as CFC is not applicable.

(5) Sunrise Senior Living’s percentage pooled consists of 47 assets under 6 separate pools.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Senior Housing Portfolio

Dollars in thousands

Portfolio Trends

	Same Property Leased Portfolio															Total Property Portfolio(1)
	As of and for the Quarter Ended									As of and for the YTD Period Ended						As of and for the Twelve Months Ended
	06/30/12			03/31/12			06/30/11			06/30/12			06/30/11			06/30/12		03/31/12(2)		06/30/11(2)
Property count	227			227			227			223			223			314		314		317
Investment	$	4,334,034		$	4,326,485		$	4,313,400		$	4,239,145		$	4,218,510		$	5,920,323	$	5,906,471	$	5,899,283
Units	26,195			26,191			26,177			25,634			25,626			36,156		36,154		36,424
3-Month Occupancy %	85.9			85.8			85.9			85.9			85.7			85.5		85.8		85.9
12-Month Occupancy %	85.7			85.7			86.3			85.5			86.1			85.6		85.7		86.3
EBITDAR	$	398,445		$	399,773		$	381,890		$	389,688		$	373,127		$	398,445	$	399,773	$	395,939
EBITDAR CFC	1.13 x			1.14 x			1.17 x			1.13 x			1.18 x			1.13 x		1.14 x		1.18 x
EBITDARM	$	477,227		$	475,716		$	457,759		$	466,947		$	457,578		$	477,227	$	475,716	$	473,821
EBITDARM CFC	1.35 x			1.36 x			1.40 x			1.36 x			1.41 x			1.35 x		1.36 x		1.41 x
NOI:
Rental and related revenues	$	86,587		$	87,253		$	86,790		$	169,591		$	170,710
DFL income	12,181			12,580			13,499			24,761			26,893
Operating expenses	(42		)	(241		)	(100		)	(279		)	(611		)
	$	98,726		$	99,592		$	100,189		$	194,073		$	196,992
Adjusted NOI:
Straight-line rents	(7,027		)	(8,147		)	(9,590		)	(14,675		)	(19,701		)
Below market lease intangibles, net	(631		)	(631		)	(631		)	(1,262		)	(1,262		)
DFL interest accretion	(1,626		)	(1,939		)	(2,348		)	(3,565		)	(5,024		)
	$	89,442		$	88,875		$	87,620		$	174,571		$	171,005

(2) Amounts are presented without giving effect to discontinued operations.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Post-Acute/Skilled Nursing Portfolio

As of and for the six months ended June 30, 2012, dollars in thousands

Investments

						Average
Leased	Property					Age		Occupancy	EBITDAR			EBITDARM
Properties	Count	Investment		NOI		(Years)	Beds	%	Amount		CFC	Amount		CFC
Operating leases	45	$	246,711	$	19,089	27	5,321	84.8	$	58,460	1.58 x	$	78,773	2.12 x
HCR ManorCare DFLs(1)	268	5,364,080		249,211		34	36,284	86.5	N/A		N/A	N/A		N/A
Leased properties	313	$	5,610,791	$	268,300	33	41,605	86.3

Debt				Interest
Investments		Investment		Income
Four Seasons Health Care(2)		$	214,860	$	149
Other		9,617		558
		224,477		707

Total		$	5,835,268	$	269,007

Operator Concentration(3)

						NOI and
	Properties		Investment			Interest Income				Occupancy	EBITDAR	EBITDARM
Operator	Count	% Pooled	Amount		%	Amount		%	Beds	%	CFC(1)	CFC(1)
HCR ManorCare(1)	268	100	$	5,364,080	92	$	249,211	93	36,284	86.5	N/A	N/A
Four Seasons Health Care(2)	—	—	214,860		4	149		—	—	—	N/A	N/A
Formation Capital	9	100	63,100		1	3,427		1	934	94.3	1.99 x	2.51 x
Covenant Care	12	100	64,291		1	5,319		2	1,328	85.1	1.76 x	2.33 x
Kindred Healthcare	9	100	38,117		1	4,199		2	1,288	84.4	1.02 x	1.66 x
Other	15	60	90,820		1	6,702		2	1,771	79.7	1.57 x	2.06 x
	313	99	$	5,835,268	100	$	269,007	100	41,605	86.3	1.58 x	2.12 x

(2) On June 28, 2012, the Company purchased senior unsecured notes of Four Seasons Health Care with an aggregate par value of ₤138.5 million at a discount for ₤136.8 million. The amount represents the carrying value translated into U.S. dollars as of June 30, 2012. For additional information see Note 10 to the Consolidated Financial Statements for the six months ended June 30, 2012 included in the Company’s Quarterly Report on Form 10-Q filed with the SEC.

(3) Property count, beds, occupancy and CFCs are presented for leased properties and exclude debt investments.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Post-Acute/Skilled Nursing Portfolio

Dollars in thousands, except HCR ManorCare information

Portfolio Trends

	Same Property Leased Portfolio															Total Leased Portfolio(1)
	As of and for the Quarter Ended									As of and for the YTD Period Ended						As of and for the Twelve Months Ended
	06/30/12			03/31/12			06/30/11			06/30/12			06/30/11			06/30/12		03/31/12(2)		06/30/11(2)
Property count	45			45			45			45			45			313		313		313
Investment	$	246,711		$	245,834		$	244,738		$	246,711		$	244,738		$	5,610,791	$	5,579,365	$	5,480,734
Beds	5,321			5,321			5,286			5,321			5,286			41,605		41,746		41,773
3-Month Occupancy %	84.7			84.7			85.5			84.7			85.5			85.9		85.5		88.2
12-Month Occupancy %	84.8			84.8			85.3			84.8			85.3			86.3		86.8		87.5
EBITDAR	$	58,460		$	60,749		$	61,545		$	58,460		$	61,545		58,460		60,749		61,545
EBITDAR CFC	1.58 x			1.64 x			1.69 x			1.58 x			1.69 x			1.58 x		1.64 x		1.69 x
EBITDARM	$	78,773		$	81,309		$	81,209		$	78,773		$	81,209		78,773		81,309		81,209
EBITDARM CFC	2.12 x			2.20 x			2.24 x			2.12 x			2.24 x			2.12 x		2.20 x		2.24 x
Quality Mix	65.4%			65.9%			63.8%			65.4%			63.8%			65.4%		65.9%		63.8%
NOI:
Rental revenues	$	9,560		$	9,616		$	9,507		$	19,176		$	18,947
Operating expenses	(32		)	(51		)	(26		)	(83		)	(41		)
	9,528			9,565			9,481			19,093			18,906

Adjusted NOI:
Straight-line rents	(102		)	(164		)	(262		)	(266		)	(585		)
	$	9,426		$	9,401		$	9,219		$	18,827		$	18,321

	*HCR ManorCare Leased Portfolio Summary*
	As of and for the six months ended June 30, 2012, dollars in thousands

	Investment	Property						Adjusted			Facility EBITDAR			Facility EBITDARM
	Summary	Count		Investment(3)		NOI(4)		NOI		Occupancy	Amount		CFC	Amount		CFC
	Assisted living	66		$	833,615	$	35,172	$	29,221	82.9%	N/A		N/A	N/A		N/A
	Post-acute/skilled	268		5,364,080		249,211		211,180		86.5%	N/A		N/A	N/A		N/A
Total		334		$	6,197,695	$	284,383	$	240,401	86.1%	$	572,154	1.21 x	$	747,893	1.58 x

		06/30/12		03/31/12		06/30/11
	Quality mix	69.9%	(5)	70.4%		70.8%

	HCR ManorCare OpCo (guarantor) fixed charge coverage(6)							1.44 x

(1) EBITDAR, EBITDARM, their respective CFC and quality mix are not presented for the disaggregated HCR ManorCare senior housing and post-acute/skilled nursing portfolios as the combined portfolio is cross-collateralized under a single master lease. For additional information see HCR ManorCare Leased Portfolio Summary.

(2) Amounts are presented as originally reported, without giving effect to discontinued operations.

(3) The Company’s total investment in HCR ManorCare includes aggregated accumulated DFL accretion of $180.7 million as of June 30, 2012.

(4) Assisted living and post-acute/skilled NOI includes reductions of $3.7 million and $25.9 million, respectively, related to HCP’s equity interest in HCR ManorCare OpCo.

(5) Private-pay and Medicare revenues as a percentage of total revenues are 31.4% and 38.5% respectively.

(6) HCR ManorCare OpCo (guarantor) fixed charge coverage is based on EBITDAR for the trailing 12 months, is one quarter in arrears from the date presented and includes home health and hospice EBITDAR and corporate general and administrative expenses, excluding HCR ManorCare’s non-recurring expenses associated with the sale of its real estate to HCP. The fixed charges include cash rent annualized and cash interest expense based on the trailing 12 months and are one quarter in arrears from the date presented.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Life Science Portfolio

As of and for the six months ended June 30, 2012, dollars and square feet in thousands

Investments

	Property					Average	Square
Leased Properties	Count	Investment		NOI		Age (Years)	Feet	Occupancy %
San Francisco	77	$	2,624,513	$	92,313	19	4,673	88.1
San Diego	21	590,364		18,787		19	1,581	89.3
Other	11	125,278		6,836		19	746	100.0
	109	$	3,340,155	$	117,936	19	7,000	89.6

Tenant Concentration

	Annualized Revenues			Square Feet
Tenant	Amount		%	Amount	%
Amgen	$	42,247	18	684	11
Genentech	38,387		17	794	13
Rigel Pharmaceuticals	13,316		6	147	2
Exelixis, Inc.	13,144		6	295	5
Takeda	10,781		5	229	4
LinkedIn Corporation	9,642		4	303	5
Google	8,319		4	270	4
Myriad Genetics	7,217		3	310	5
General Atomics	5,713		2	281	4
ARUP	5,418		2	324	5
Other	75,576		33	2,637	42
	$	229,760	100	6,274	100

Portfolio Trends

	Same Property Leased Portfolio															Total Leased Portfolio
	As of and for the Quarter Ended									As of and for the YTD Period Ended						At the Period Ended
	06/30/12			03/31/12			06/30/11			06/30/12			06/30/11			06/30/12		03/31/12(1)		06/30/11(1)
Property count	101			101			101			101			101			109		108		104
Investment	$	3,207,732		$	3,204,642		$	3,200,225		$	3,207,732		$	3,200,225		$	3,340,155	$	3,331,015	$	3,251,372
Square feet	6,685			6,685			6,685			6,685			6,685			7,000		6,924		6,798
Occupancy %	91.5			91.1			90.4			91.5			90.4			89.6		89.1		89.2
NOI:
Rental and related revenues	$	60,697		$	60,830		$	61,266		$	121,527		$	122,321
Tenant recoveries	11,016			10,279			9,833			21,295			20,547
Operating expenses	(12,351		)	(11,687		)	(11,609		)	(24,038		)	(23,622		)
	$	59,362		$	59,422		$	59,490		$	118,784		$	119,246
Adjusted NOI:
Straight-line rents	(3,081		)	340			(3,765		)	(2,741		)	(7,922		)
Above (below) market lease intangibles, net	128			89			(340		)	217			(381		)
Lease termination fees	—			—			(1,589		)	—			(3,178		)
	$	56,409		$	59,851		$	53,796		$	116,260		$	107,765

(1) Amounts are presented as originally reported, without giving effect to discontinued operations.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Life Science Portfolio

Dollars and square feet in thousands, except dollars per square foot

Selected Lease Expirations Data (next 3 years):

	Total					San Francisco			San Diego			Other
	Square Feet		Annualized Revenues			Square	Annualized		Square	Annualized		Square	Annualized
Year	Amount	%	Amount		%	Feet	Revenues		Feet	Revenues		Feet	Revenues
2012(1)	91	1	$	1,722	1	42	$	166	49	$	1,556	—	$	—
2013	471	8	11,528		5	365	10,214		29	628		77	686
2014	342	5	10,156		4	215	6,565		127	3,591		—	—
Thereafter	5,370	86	206,354		90	3,494	155,625		1,207	37,609		669	13,120
	6,274	100	$	229,760	100	4,116	$	172,570	1,412	$	43,384	746	$	13,806

*Leasing Activity*	Leased		Annualized		%		HCP Tenant		Leasing		Average	Retention
	Square		Base Rent Per		Change		Improvements		Costs Per		Lease Term	Rate
	Feet		Square Foot		In Rents		Per Square Foot		Square Foot		(Months)	YTD
Leased Square Feet as of December 31, 2011	6,113		$	36.24
Redevelopments placed in service	54		27.68
Expirations	(194	)	31.44
Renewals, amendments and extensions	160		28.45		(9.0	)	$	5.63	$	9.38	110	82.3
New leases and expansions	75		29.39				18.91		7.90		67
Terminations	(41	)	33.84
Leased Square Feet as of March 31, 2012	6,167		$	36.74

Acquisitions	77			9.79
Expirations	(83	)		21.13
Renewals, amendments and extensions	65			23.91	0.1		$	—	$	1.12	20	81.1
New leases and expansions	48			11.82			—		1.92		81

Leased Square Feet as of June 30, 2012	6,274		$	36.62

(1) Includes month-to-month and holdover leases.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Medical Office Portfolio

As of and for the six months ended June 30, 2012, dollars and square feet in thousands

Investments

	Property					Average
Leased Properties	Count	Investment		NOI		Age (Years)	Square Feet	Occupancy %
On-Campus	141	$	1,832,746	$	78,478	20	10,737	91.3
Off-Campus	44	462,863		18,700		19	2,235	92.1
	185	$	2,295,609	$	97,178	20	12,972	91.4

Portfolio Trends

	Same Property Leased Portfolio															Total Leased Portfolio
	As of and for the Quarter Ended									As of and for the YTD Period Ended						At the Period Ended
	06/30/12			03/31/12			06/30/11			06/30/12			06/30/11			06/30/12		03/31/12(1)		06/30/11(1)
Property count	185			185			185			184			184			185		186		188
Investment	$	2,285,357		$	2,274,301		$	2,247,469		$	2,253,535		$	2,215,983		$	2,295,609	$	2,286,122	$	2,272,818
Square feet	12,921			12,871			12,884			12,788			12,752			12,972		12,950		13,097
Occupancy %	91.4			91.2			90.9			91.3			90.8			91.4		91.2		91.1
NOI:
Rental and related revenues	$	68,856		$	67,727		$	67,234		$	135,235		$	132,905
Tenant recoveries	11,806			11,593			11,869			22,646			23,380
Operating expenses	(30,483		)	(29,935		)	(30,135		)	(59,667		)	(59,893		)
	$	50,179		$	49,385		$	48,968		$	98,214		$	96,392
Adjusted NOI:
Straight-line rents	(1,044		)	(1,354		)	(1,494		)	(2,298		)	(3,539		)
Above market lease intangibles, net	83			89			81			162			188
Lease termination fees	(251		)	—			—			(251		)	—
	$	48,967		$	48,120		$	47,555		$	95,827		$	93,041

(1) Amounts are presented as originally reported, without giving effect to discontinued operations.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Medical Office Portfolio

Square feet in thousands

Leasing Activity

	Leased		Annualized		%	HCP Tenant			Leasing		Average	Retention
	Square		Base Rent Per		Change	Improvements			Costs Per		Lease Term	Rate
	Feet		Square Foot		In Rents(1)	Per Square Foot			Square Foot		(Months)	YTD
Leased Square Feet as of December 31, 2011	12,001		$	22.13
Dispositions/redevelopment	(143	)	15.59
Expirations	(462	)	22.81
Renewals, amendments and extensions	376		23.16		0.8	$		12.64	$	2.55	58	81.4
New leases	64		19.75			14.38			3.63		50
Terminations	(23	)	21.31
Leased Square Feet as of March 31, 2012	11,813		$	22.41

Dispositions/redevelopment	(70	)		17.50
Expirations	(449	)		22.32
Renewals, amendments and extensions	338			22.39	0.5	$	8.55		$	2.77	50	78.4
New leases	247			19.30		19.69			3.33		56
Terminations	(20	)		20.68

Leased Square Feet as of June 30, 2012	11,859		$	22.50

(1) For comparative purposes, the calculation reflects adjustments for leases that converted to a different lease type upon renewal, amendment or extension of the original lease.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Hospital Portfolio

As of and for the six months ended June 30, 2012, dollars in thousands

Investments

Leased	Property					Average		Occupancy	EBITDAR(1)				EBITDARM(1)
Properties	Count	Investment		NOI		Age (Years)	Beds	%(1)	Amount			CFC	Amount		CFC
Acute care	5	$	452,672	$	28,835	35	1,578	50.6	$		319,454	5.46 x	$	345,558	5.90 x
Rehab	7	96,606		4,663		22	520	59.2	28,881			3.23 x	33,002		3.69 x
Specialty	2	63,725		2,533		28	68	—	19,181			3.71 x	21,196		4.10 x
LTACH	3	35,205		4,091		18	244	48.4	5,823			0.80 x	8,992		1.24 x
	17	$	648,208	$	40,122	26	2,410	52.6	$	373,339		4.67 x	$	408,748	5.12 x

Debt				Interest
Investments		Investment		Income
Acute care		$	15,119	$	518
Specialty(2)			68,784		—
		$	83,903	$	518

Total		$	732,111	$	40,640

Operator Concentration(3)

						NOI and
	Properties		Investment			Interest Income
Operator(1)	Count	% Pooled	Amount		%	Amount		%	Beds
Tenet Healthcare	3	—	$	196,709	27	$	11,574	28	756
HCA	1	—	167,164		23	10,453		26	668
Delphis	2	—	132,509		18	2,533		6	68
Hoag Memorial Hospital Presbyterian	1	—	88,800		12	6,811		17	154
Other	10	70	146,929		20	9,269		23	764
	17	41	$	732,111	100	$	40,640	100	2,410


(1)		Certain operators in HCP’s hospital portfolio are not required under their respective leases to provide operational data.
(2)		Represents a senior secured loan to Delphis that was placed on non-accrual status effective January 1, 2011. For additional information regarding the senior secured loan to Delphis see Note 7 to the Consolidated Financial Statements for the quarter ended June 30, 2012 included in the Company’s Quarterly Report on Form 10-Q filed with the SEC.
(3)		Property count and beds are presented for leased properties and exclude debt investments.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Owned Hospital Portfolio

Dollars in thousands

Portfolio Trends

	Same Property Leased Portfolio															Total Leased Portfolio
	As of and for the Quarter Ended									As of and for the YTD Period Ended						As of and for the Twelve Months Ended
	06/30/12			03/31/12			06/30/11			06/30/12			06/30/11			06/30/12				03/31/12(1)		06/30/11(1)

Property count	16			16			16			16			16			17				17		17
Investment	$	608,463		$	607,456		$	608,641		$	608,463		$	608,641		$			648,208	$	647,201	$	648,386
Beds	2,379			2,379			2,361			2,379			2,361			2,410				2,410		2,361
3-Month Occupancy %	56.3			51.7			56.2			56.3			56.2			56.3				51.7		56.2
12-Month Occupancy %	52.6			52.5			54.5			52.6			54.5			52.6				52.5		54.5
EBITDAR	$	364,098		$	346,009		$	296,542		$	364,098		$	296,542		$		373,339		$	355,101	$	305,868
EBITDAR CFC	4.73 x			4.52 x			4.68 x			4.73 x			4.68 x			4.67 x				4.46 x		4.62 x
EBITDARM	$	398,473		$	380,531		$	328,263		$	398,473		$	328,263		$	408,748			$	390,744	$	338,984
EBITDARM CFC	5.18 x			4.97 x			5.18 x			5.18 x			5.18 x			5.12 x				4.91 x		5.12 x
NOI:
Rental and related revenues	$	21,848		$	18,614		$	21,524		$	40,462		$	39,635
Operating expenses	(936		)	(929		)	(1,221		)	(1,865		)	(2,186		)
	$	20,912		$	17,685		$	20,303		$	38,597		$	37,449
Adjusted NOI:
Straight-line rents	(161		)	(184		)	(254		)	(345		)	(529		)
Below market lease intangibles, net	(193		)	(192		)	(192		)	(385		)	(385		)
	$	20,558		$	17,309		$	19,857		$	37,867		$	36,535

(1) Amounts are presented as originally reported, without giving effect to discontinued operations.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Investment Management Platform

As of and for the six months ended June 30, 2012, dollars and square feet in thousands

							Joint				HCP’s
Unconsolidated		Date	HCP’s		Joint		Venture’s		HCP’s Net		Investment		Initial
Institutional	Primary	Established/	Ownership		Venture’s		Mortgage		Equity		Management		Term
Joint Ventures	Segment	Acquired	Percentage		Investment		Debt		Investment(1)		Fee Income		(in years)
HCP Ventures III	Medical office	October-06		30%(2)	$	143,557	$	91,730	$	8,012	$	193	10
HCP Ventures IV	Medical office	April-07		20%	659,965		374,055		33,964		768		10
HCP Life Science	Life science	August-07	50%-63%		144,481		4,830		66,883		2		97-98
					$	948,003	$	470,615	$	108,859	$	963

Selected Financial Data(3)

	Three Months Ended June 30, 2012						Six Months Ended June 30, 2012
	Medical Office			Life Science			Medical Office			Life Science
Total revenues	$	19,101		$	2,741		$	38,801		$	5,475
Operating expenses	(8,096		)	(403		)	(15,915		)	(801		)
NOI	$	11,005		$	2,338		$	22,886		$	4,674
Depreciation and amortization	(7,173		)	(396		)	(14,167		)	(790		)
General and administrative	(999		)	(8		)	(1,815		)	(25		)
Interest expense and other	(6,769		)	(97		)	(13,500		)	(209		)
Net income (loss)	$	(3,936	)	$	1,837		$	(6,596	)	$	3,650
Depreciation and amortization	7,173			396			14,167			790
FFO	$	3,237		$	2,233		$	7,571		$	4,440
Amortization of above and below market lease intangibles, net	(186		)	—			(370		)	—
Amortization of deferred financing costs, net	162			9			352			17
Straight-line rents	(156		)	98			(562		)	178
Leasing costs and tenant and capital improvements	(2,670		)	(10		)	(4,134		)	(2		)
FAD	$	387		$	2,330		$	2,857		$	4,633

HCP’s pro rata share of net income (loss)	$	(792	)	$	1,074		$	(1,325	)	$	2,135

HCP’s pro rata share of FFO	$	769		$	1,291		$	1,759		$	2,567

HCP’s pro rata share of FAD	$	177		$	1,343		$	768		$	2,672

	Property					Adjusted		Average	Square
HCP Ventures III	Count	Investment		NOI		NOI		Age (Years)	Feet	Occupancy %(4)
Medical office:
On-Campus	9	$	109,779	$	4,581	$	4,502	12	619	98.6
Off-Campus	4	33,778		1,109		1,106		11	183	86.9
	13	$	143,557	$	5,690	$	5,608	11	802	95.9

HCP Ventures IV
Medical office:
On-Campus	22	$	216,897	$	5,393	$	5,397	24	1,103	75.9
Off-Campus	31	361,685		9,874		9,215		20	1,487	83.1
Hospital:
LTACH	1	12,193		24		24		6	N/A	N/A
Specialty	3	69,190		1,905		1,670		7	N/A	N/A
	57	$	659,965	$	17,196	$	16,306	21

HCP Life Science
San Francisco	2	$	74,700	$	2,362	$	2,526	15	147	100.0
San Diego	2	69,781		2,312		2,324		16	131	90.3
	4	$	144,481	$	4,674	$	4,850	16	278	95.4
Total	74	$	948,003	$	27,560	$	26,764


(1)	The carrying value of investments in unconsolidated joint ventures is based on the amount the Company paid to purchase the joint venture interest, which is different from the Company’s capital balance as reflected at the joint venture level as the records of the unconsolidated joint venture are reflected at their historical cost. These differences in basis are generally amortized over the lives of the related assets and liabilities and included in the Company’s share of equity in earnings of the respective joint venture.
(2)	The Company owns an 85% interest in HCP Birmingham Portfolio LLC, which owns a 30% interest in HCP Ventures III.
(3)	Financial information is combined by primary segment of each joint venture (i.e., HCP Ventures III and HCP Ventures IV are combined under the medical office column).
(4)	Certain operators in the Investment Management Platform hospital portfolio are not required under their respective leases to provide operational data.

See Reporting Definitions and Reconciliations of Non-GAAP Measures

Reporting Definitions and Reconciliations of Non-GAAP Measures

Adjusted Fixed Charge Coverage. Adjusted EBITDA divided by Fixed Charges. The Company uses Adjusted Fixed Charge Coverage, a non-GAAP financial measure, as a measure of liquidity. The Company believes Adjusted Fixed Charge Coverage provides investors, particularly fixed income investors, relevant and useful information because it measures the Company’s ability to meet its interest payments on outstanding debt and pay dividends to its preferred stockholders. The Company’s various debt agreements contain covenants that require the Company to maintain ratios similar to Adjusted Fixed Charge Coverage, and credit rating agencies utilize similar ratios in evaluating and determining the credit rating on certain debt instruments of the Company. However, since this ratio is derived from Adjusted EBITDA and Fixed Charges, its usefulness is limited by the same factors that limit the usefulness of Adjusted EBITDA and Fixed Charges. Further, the Company’s computation of Adjusted Fixed Charge Coverage may not be comparable to similar fixed charge coverage ratios reported by other companies. The Company has provided reconciliations of this measure to the most comparable GAAP measure in this supplemental information package and for certain historical trend information on page 6, such reconciliations are available in the Company’s Current Reports on Form 8-K filed with the SEC dated February 14, 2012 (2011 metrics), February 15, 2011 (2010 metrics), February 12, 2010 (2009 metrics), February 10, 2009 (2008 metrics), February 11, 2008 (2008 and 2007 metrics) and July 30, 2007 (Pre-CNL Acquisition metrics).

The following table details the calculation of Adjusted Fixed Charge Coverage (dollars in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2012		2011		2012		2011

Adjusted EBITDA	$	399,116	$	432,365	$	790,062	$	701,834
Interest expense:
Continuing operations	$	103,225	$	105,129	$	207,793	$	213,705
HCP’s share of interest expense from the Investment Management Platform	1,553		1,584		3,106		3,159
Capitalized interest	6,812		6,550		13,495		12,538
Preferred stock dividends	—		5,283		6,574		10,566
Fixed charges	$	111,590	$	118,546	$	230,968	$	239,968

Adjusted fixed charge coverage	3.6x		3.6x		3.4x		2.9x

Annualized Revenues. The most recent month’s (or subsequent month’s if acquired in the most recent month) base rent including additional rent floors, cash income from direct financing leases and/or interest income annualized for 12 months. Annualized Revenues for operating properties under a RIDEA structure are calculated based on the most recent monthly NOI annualized for 12 months. Annualized Revenues do not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e., straight-line rents, amortization of above and below market lease intangibles, DFL interest accretion and deferred revenues). The Company uses Annualized Revenues for the purpose of determining Operator/Tenant Diversification, Lease Expirations and Debt Investment Maturities.

Assets Held for Sale. Assets of discontinued operations in accordance with Accounting Standards Codification Topic 360.

Assisted Living Facility (“ALF”). A senior housing facility that predominantly consists of assisted living units is classified by the Company as an ALF.

Cash Flow Coverage (“CFC”). Facility EBITDAR or Facility EBITDARM for the trailing 12 months and one quarter in arrears from the date reported divided by the Same Period Rent. Cash Flow Coverage is a supplemental measure of a property’s ability to generate cash flows for the operator/tenant (not the Company) to meet the operator’s/tenant’s related rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of Facility EBITDAR or Facility EBITDARM. The coverages shown exclude newly completed facilities under start-up, vacant facilities and facilities for which data is not available or meaningful.

Consolidated Assets. Total assets as reported in the Company’s consolidated financial statements.

Consolidated Debt. The carrying amount of bank line of credit, bridge and term loans (if applicable), senior unsecured notes, mortgage and other secured debt, and other debt as reported in the Company’s consolidated financial statements.

Consolidated Gross Assets. The carrying amount of total assets, excluding investments in and advances to unconsolidated joint ventures, after adding back accumulated depreciation and amortization, as reported in the Company’s consolidated financial statements.

Consolidated Secured Debt. Mortgage and other debt secured by real estate, excluding debt on assets held for sale as reported in the Company’s consolidated financial statements.

Continuing Care Retirement Community (“CCRC”). A senior housing facility which provides at least three levels of care (i.e., independent living, assisted living and skilled nursing) is classified by the Company as a CCRC.

Debt Investments. Loans secured by a direct interest in real estate and mezzanine loans.

Debt Service. The periodic payment of interest expense and principal amortization on secured loans.

Development. Includes ground-up construction and redevelopments.

Direct Financing Lease (“DFL”). The Company uses the direct finance method of accounting to record income from DFLs. For leases accounted for as DFLs, future minimum lease payments are recorded as a receivable. The difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield.

Estimated Completion Date. For development projects, management’s estimate of the date the core and shell structure improvements are expected to be or have been completed. For redevelopment projects, management’s estimate of the time in which major construction activity in relation to the scope of the project has been substantially completed.

Reporting Definitions and Reconciliations of Non-GAAP Measures

EBITDA and Adjusted EBITDA. The real estate industry uses earnings before interest, taxes, depreciation and amortization (“EBITDA”), a non-GAAP financial measure, as a measure of both operating performance and liquidity. Adjusted EBITDA is calculated as EBITDA excluding impairments, gains or losses from real estate dispositions, and litigation settlement charge. The Company uses EBITDA and Adjusted EBITDA to measure both its operating performance and liquidity. The Company considers Adjusted EBITDA to provide investors relevant and useful information because it permits investors to view income from its operations on an unleveraged basis before the effects of taxes, non-cash depreciation and amortization, impairments, impairment recoveries, and gains or losses from real estate dispositions. By excluding interest expense, Adjusted EBITDA allows investors to measure the Company’s operating performance independent of its capital structure and indebtedness and, therefore, allows for a more meaningful comparison of its operating performance between quarters as well as annual periods and to compare its operating performance to that of other companies, both in the real estate industry and in other industries. As a liquidity measure, the Company believes that EBITDA and Adjusted EBITDA help investors analyze the Company’s ability to meet its interest payments on outstanding debt and to make preferred dividend payments. The Company believes investors should consider EBITDA and Adjusted EBITDA, in conjunction with net income (the primary measure of the Company’s performance) and the other required GAAP measures of its performance and liquidity, to improve their understanding of the Company’s operating results and liquidity, and to make more meaningful comparisons of its performance between periods and against other companies. EBITDA and Adjusted EBITDA have limitations as analytical tools and should be used in conjunction with the Company’s required GAAP presentations. EBITDA and Adjusted EBITDA do not reflect the Company’s historical cash expenditures or future cash requirements for capital expenditures or contractual commitments. While Adjusted EBITDA is a relevant and widely used measure of operating performance and liquidity, it does not represent net income or cash flow from operations as defined by GAAP, and it should not be considered as an alternative to those indicators in evaluating operating performance or liquidity. Further, the Company’s computation of EBITDA and Adjusted EBITDA may not be comparable to similar measures reported by other companies.

The following table reconciles Adjusted EBITDA from net income (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011

Net income	$	204,975		$	234,252		$	401,539		$	308,236
Interest expense:
Continuing operations	103,225			105,129			207,793			213,705
Income taxes:
Continuing operations	176			248			(533		)	285
Discontinued operations	—			—			103			—
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	87,924			89,814			176,165			180,996
Discontinued operations	—			238			35			476
Equity income from unconsolidated joint ventures	(15,732		)	(14,950		)	(29,407		)	(15,748		)
HCP’s share of EBITDA from the Investment Management Platform	3,612			3,872			7,432			7,969
Other joint venture adjustments	14,936			13,492			29,791			13,684
EBITDA	$	399,116		$	432,095		$	792,918		$	709,603

Gain on sales of real estate	—			—			(2,856		)	—
Gain upon consolidation of joint venture	—			270			—			(7,769		)
Adjusted EBITDA	$	399,116		$	432,365		$	790,062		$	701,834

Facility EBITDAR (“EBITDAR”). Earnings before interest, taxes, depreciation, amortization and rent for a particular facility accruing to the operator/tenant of the property (not the Company), for the trailing 12 months and one quarter in arrears from the date reported. The Company uses Facility EBITDAR in determining Cash Flow Coverage and Debt Service Coverage. Facility EBITDAR has limitations as an analytical tool. Facility EBITDAR does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, Facility EBITDAR does not represent a property’s net income or cash flow from operations and should not be considered an alternative to those indicators. However, the Company receives periodic financial information from operators/tenants regarding the performance of the Company’s facilities under the operator’s/tenant’s management. The Company utilizes Facility EBITDAR as a supplemental measure of the ability of those properties to generate sufficient liquidity to meet related obligations to the Company. Facility EBITDAR includes the greater of (i) contractual management fees or (ii) an imputed management fee of 5% for senior housing facilities and post-acute/skilled nursing facilities and 2% for acute care hospitals which the Company believes represents typical management fees in their respective industries. All facility financial performance data was derived solely from information provided by operators/tenants and borrowers without independent verification by the Company.

Facility EBITDARM (“EBITDARM”). Earnings before interest, taxes, depreciation, amortization, rent and management fees for a particular facility accruing to the operator/tenant of the property (not the Company), for the trailing 12 months and one quarter in arrears from the date reported. The Company uses Facility EBITDARM in determining Cash Flow Coverage and Debt Service Coverage. Facility EBITDARM has limitations as an analytical tool. Facility EBITDARM does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, Facility EBITDARM does not represent a property’s net income or cash flow from operations and should not be considered an alternative to those indicators. However, the Company receives periodic financial information from operators/tenants regarding the performance of the Company’s facilities under the operator’s/tenant’s management. The Company utilizes Facility EBITDARM as a supplemental measure of the ability of those properties to generate sufficient liquidity to meet related obligations to the Company. All facility financial performance data was derived solely from information provided by operators/tenants and borrowers without independent verification by the Company.

Reporting Definitions and Reconciliations of Non-GAAP Measures

Financial Leverage. Total Debt divided by Total Gross Assets. The Company believes that its Financial Leverage is a meaningful supplemental measure of its financial position, which enables both management and investors to analyze its leverage and to compare its leverage to that of other companies. The Company believes that the ratio of Consolidated Debt to Consolidated Gross Assets is the most directly comparable GAAP measure to Financial Leverage. The Company’s computation of its Financial Leverage may not be identical to the computations of financial leverage reported by other companies. The Company’s pro rata share of total debt from the Investment Management Platform is not intended to reflect its actual liability or ability to access assets should there be a default under any or all such loans or a liquidation of the joint ventures. The Company has provided reconciliations of this measure to the most comparable GAAP measure in this supplemental information package and for certain historical trend information on page 6, such reconciliations are available in the Company’s Current Reports on Form 8-K filed with the SEC dated February 14, 2012 (2011 metrics), February 15, 2011 (2010 metrics), February 12, 2010 (2009 metrics), February 10, 2009 (2008 metrics), February 11, 2008 (2008 and 2007 metrics) and July 30, 2007 (Pre-CNL Acquisition metrics).

Fixed Charges. Total interest expense plus capitalized interest plus preferred stock dividends. The Company uses Fixed Charges to measure its interest payments on outstanding debt and dividends to its preferred stockholders for purposes of presenting Fixed Charge Coverage and Adjusted Fixed Charge Coverage. However, the usefulness of Fixed Charges is limited as, among other things, it does not include all contractual obligations. The Company’s computation of Fixed Charges should not be considered an alternative to fixed charges as defined by Item 503(d) of Regulation S-K and may not be comparable to fixed charges reported by other companies.

Funds Available for Distribution (“FAD”). Funds Available for Distribution is defined as FFO as adjusted after excluding the impact of the following: (i) amortization of acquired above/below market lease intangibles, net; (ii) amortization of deferred compensation expense; (iii) amortization of deferred financing costs, net; (iv) straight-line rents; (v) accretion and depreciation related to DFLs; and (vi) deferred revenues. Further, FAD is computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements, and includes similar adjustments to compute the Company’s share of FAD from its unconsolidated joint ventures. Other real estate investment trusts (“REITs”) or real estate companies may use different methodologies for calculating FAD, and accordingly, the Company’s FAD may not be comparable to those reported by other REITs. Although the Company’s FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of the Company’s ability to fund its ongoing dividend payments. In addition, management believes that in order to further understand and analyze the Company’s liquidity, FAD should be compared with cash flows as determined in accordance with GAAP and presented in its consolidated financial statements. FAD does not represent cash generated from operating activities determined in accordance with GAAP, and FAD should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of the Company’s performance, as an alternative to net cash flows from operating activities (determined in accordance with GAAP), or as a measure of the Company’s liquidity.

Funds From Operations (“FFO”). The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company also believes that Funds From Operations, or FFO, as defined by the National Association of Real Estate Investment Trusts (“NAREIT”), FFO applicable to common shares, Diluted FFO applicable to common shares, and Basic and Diluted FFO per common share are important non-GAAP supplemental measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. Thus, NAREIT created FFO as a supplemental measure of operating performance for REIT that excludes historical cost depreciation and amortization, among other items, from net income, as defined by GAAP. FFO is defined as net income (determined in accordance with GAAP), excluding gains or losses from acquisition and dispositions of depreciable real estate or related interests, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, with adjustments to derive the Company’s pro rata share of FFO from consolidated and unconsolidated joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. The Company believes that the use of FFO, combined with the required GAAP presentations, improves the understanding of operating results of REITs among investors and makes comparisons of operating results among such companies more meaningful. The Company considers FFO to be a useful measure for reviewing comparative operating and financial performance because, by excluding gains or losses related to sales of previously depreciated operating real estate assets and real estate and DFL depreciation and amortization, FFO can help investors compare the operating performance of a REIT between periods or as compared to other companies. While FFO is a relevant and widely used measure of operating performance of REITs, it does not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. FFO also does not consider the costs associated with capital expenditures related to the Company’s real estate assets, nor is FFO necessarily indicative of cash available to fund the Company’s future cash requirements. The Company’s computation of FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or that interpret the current NAREIT definition differently from the Company. For a reconciliation of FFO to net income, please refer to the slide in this supplemental information package captioned “Consolidated Funds From Operations.”

FFO as adjusted represents FFO before the impact of litigation settlement charges, preferred stock redemption charges, impairments (recoveries) of non-depreciable assets and merger-related items. Merger-related items include estimated acquisition pursuit costs that consist primarily of professional fees and the impact of common stock offerings which increase the weighted average shares outstanding, when such proceeds will be used to fund a portion of the cash consideration of the Company’s pending acquisitions. Management believes FFO as adjusted is a useful alternative measurement. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income (determined in accordance with GAAP).

FAD Payout Ratio. Dividends declared per common share divided by Diluted FAD per common share for a given period. The Company believes the FAD Payout Ratio per Common Share provides investors relevant and useful information because it measures the portion of FAD being declared as dividends to common stockholders. FAD Payout Ratio per Common Share is subject to the same limitations noted in the definition of FAD above.

FFO Payout Ratio. Dividends declared per common share divided by Diluted FFO per common share for a given period. The Company believes the FFO Payout Ratio per Common Share provides investors relevant and useful information because it measures the portion of FFO being declared as dividends to common stockholders. FFO Payout Ratio per Common Share is subject to the same limitations noted in the definition of FFO above.

Reporting Definitions and Reconciliations of Non-GAAP Measures

HCP Life Science. Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships: (i) Torrey Pines Science Center LP (50%), (ii) Britannia Biotech Gateway LP (55%) and (iii) LASDK LP (63%). The unconsolidated joint ventures were acquired as part of the Company’s purchase of Slough Estates USA Inc. on August 1, 2007.

HCP Ventures III. An unconsolidated joint venture formed on October 27, 2006 between the Company and an institutional capital partner, for which the Company is the managing member and has an effective 25.5% interest.

HCP Ventures IV. An unconsolidated joint venture formed on April 30, 2007 between the Company and an institutional capital partner, for which the Company is the managing member and has a 20% interest.

Independent Living Facility (“ILF”). A senior housing facility that predominantly consists of independent living units.

Investment. Represents (i) the carrying amount of real estate assets, including intangibles, after adding back accumulated depreciation and amortization, excluding assets held for sale and classified as discontinued operations and (ii) the carrying amount of DFLs and debt investments.

Investment Management Platform. Includes the following unconsolidated joint ventures: (i) HCP Life Science, (ii) HCP Ventures III and (iii) HCP Ventures IV.

Life Science. Laboratory and office space primarily for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry.

Long-Term Acute Care Hospitals (“LTACHs”). LTACHs provide care for patients with complex medical conditions that require longer stays and more intensive care, monitoring or emergency back-up than that available in most skilled nursing-based programs.

Net Operating Income from Continuing Operations (“NOI”). A non-GAAP supplemental financial measure used to evaluate the operating performance of real estate properties and SPP. The Company defines NOI as rental and related revenues, including tenant recoveries, resident fees and services, and income from DFLs, less property level operating expenses. NOI excludes interest income, investment management fee income, interest expense, depreciation and amortization, general and administrative expenses, litigation settlement, impairments, impairment recoveries, other income, net, income taxes, equity income from and impairments of unconsolidated joint ventures, and discontinued operations. The Company believes NOI provides investors relevant and useful information because it reflects only income and operating expense items that are incurred at the property level and presents them on an unleveraged basis. Adjusted NOI is calculated as NOI eliminating the effects of straight-line rents, DFL accretion, amortization of above and below market lease intangibles, and lease termination fees. Adjusted NOI is sometimes referred to as “cash NOI.” The Company uses NOI and adjusted NOI to make decisions about resource allocations, to assess and compare property level performance, and evaluate SPP. The Company believes that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income (determined in accordance with GAAP) since it does not reflect the aforementioned excluded items. Further, NOI may not be comparable to that of other REITs, as they may use different methodologies for calculating NOI.

The following table reconciles NOI from net income (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Net income	$	204,975		$	234,252		$	401,539		$	308,236
Interest income	(1,216		)	(60,526		)	(2,035		)	(98,622		)
Investment management fee income	(470		)	(504		)	(963		)	(1,111		)
Interest expense	103,225			105,129			207,793			213,705
Depreciation and amortization	87,924			89,814			176,165			180,996
General and administrative	14,812			34,872			34,914			56,824
Other income, net	(1,028		)	(7,518		)	(1,464		)	(17,827		)
Income taxes	176			248			(533		)	285
Equity income from unconsolidated joint ventures	(15,732		)	(14,950		)	(29,407		)	(15,748		)
Total discontinued operations, net of taxes	—			(337		)	(2,993		)	(678		)
NOI	$	392,666		$	380,480		$	783,016		$	626,060

Straight-line rents	(11,860		)	(15,612		)	(21,787		)	(32,912		)
DFL accretion	(22,017		)	(22,262		)	(47,639		)	(24,937		)
Amortization of above and below market lease intangibles, net	(625		)	(1,187		)	(1,322		)	(2,093		)
Lease termination fees	(251		)	(1,589		)	(399		)	(3,178		)
NOI adjustments related to discontinued operations	—			—			148			—
Adjusted NOI	$	357,913		$	339,830		$	712,017		$	562,940

Occupancy. For life science facilities and medical office buildings, occupancy represents the percentage of total rentable square feet leased where rental payments have commenced, including month-to-month leases, as of the end of the period reported. For senior housing facilities, post-acute/skilled nursing facilities and hospitals, occupancy represents the facilities’ average operating occupancy for the trailing three-month and 12-month periods and one quarter in arrears from the date reported. The percentages are calculated based on units, licensed beds and available beds for senior housing facilities, post-acute/skilled nursing facilities and hospitals, respectively. The percentages shown exclude newly completed facilities under lease-up, vacant facilities and facilities for which data is not available or meaningful. All facility financial performance data was derived solely from information provided by operators/tenants and borrowers without independent verification by the Company. For the SPP, occupancy for senior housing facilities, post-acute/skilled nursing facilities and hospitals are presented based on the average operating occupancy for the trailing three-month and 12-month periods and one quarter in arrears from the date reported.

Owned Portfolio. Represents owned properties subject to operating leases and DFLs, properties operated under a RIDEA structure and debt investments, and excludes properties under development, including redevelopment, land held for development and real estate owned by the Company’s unconsolidated joint ventures.

Reporting Definitions and Reconciliations of Non-GAAP Measures

Pooled Leases. Two or more leases to the same operator/tenant or their subsidiaries under which their obligations are combined by virtue of a master lease or multiple master leases, a pooling agreement or multiple pooling agreements, or cross-guaranties. For example, Sunrise Senior Living percentage pooled consists of 47 assets under 6 separate pools.

Quality Mix. Represents non-Medicaid revenues as a percent of total revenues for the trailing 12 months and is one quarter in arrears from the period presented.

Redevelopment Projects. Properties that require significant capital expenditures (generally more than 25% of acquisition cost or existing basis) to achieve stabilization or to change the use of the properties.

Rehabilitation Hospitals (“Rehab”). Rehabilitation hospitals provide inpatient and outpatient care for patients who have sustained traumatic injuries or illnesses, such as spinal cord injuries, strokes, head injuries, orthopedic problems, work-related disabilities and neurological diseases.

Rental and RIDEA Revenues. Represents rental and related revenues, tenant recoveries, resident fees and services, and income from direct financing leases.

Retention Rate. Represents the ratio of total renewed square feet to the total square feet expiring and available for lease, excluding the square feet for tenant leases terminated for default or buy-out prior to the expiration of their lease.

RIDEA. The Housing and Economic Recovery Act of 2008 (commonly referred to as “RIDEA”).

Same Period Rent. The base rent plus additional rent due to the Company over the trailing 12 months and one quarter in arrears from the date reported. The Company uses Same Period Rent for purposes of determining property-level Cash Flow Coverage.

Same Property Portfolio (“SPP”). SPP statistics allow management to evaluate the performance of the Company’s real estate portfolio under a consistent population, which eliminates the changes in the composition of the Company’s portfolio of properties. The Company identifies its SPP as stabilized properties that remained in operations and were consistently reported as leased properties or operating properties (RIDEA) for the duration of the year-over-year comparison periods presented. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in the Company’s SPP. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis.

Secured Debt Ratio. Total Secured Debt divided by Total Gross Assets. The Company believes that its Secured Debt Ratio is a meaningful supplemental measure of its financial position, which enables both management and investors to analyze its leverage and to compare its leverage to that of other companies. The Company believes that the ratio of Consolidated Secured Debt to Consolidated Gross Assets is the most directly comparable GAAP measure to Secured Debt Ratio. The Company’s computation of its Secured Debt Ratio may not be identical to the computations of Secured Debt Ratio reported by other companies. The Company’s pro rata share of total secured debt from the Investment Management Platform is not intended to reflect its actual liability or ability to access assets should there be a default under any or all such loans or a liquidation of the joint ventures. The Company has provided reconciliations of this measure to the most comparable GAAP measure in this supplemental information package and for certain historical trend information on page 6, such reconciliations are available in the Company’s Current Reports on Form 8-K filed with the SEC dated February 14, 2012 (2011 metrics), February 15, 2011 (2010 metrics), February 12, 2010 (2009 metrics), February 10, 2009 (2008 metrics), February 11, 2008 (2008 and 2007 metrics) and July 30, 2007 (Pre-CNL Acquisition metrics).

Senior Housing. ALFs, ILFs and CCRCs.

Specialty Hospitals. Specialty hospitals are licensed as acute care hospitals but focus on providing care in specific areas such as cardiac, orthopedic and women’s conditions, or specific procedures such as surgery, and are less likely to provide emergency services.

Square Feet. The square footage for properties, excluding square footage for development or redevelopment properties prior to completion.

Stabilized. Newly acquired operating assets are generally considered stabilized at the earlier of lease up (typically when the tenant(s) controls the physical use of 80% of the space) or 12 months from the acquisition date. Newly completed developments, including redevelopments, are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service.

Total Debt. Consolidated Debt at book value plus the Company’s pro rata share of total debt from the Investment Management Platform.

Total Gross Assets. Consolidated Gross Assets plus the Company’s pro rata share of total assets from the Investment Management Platform, after adding back accumulated depreciation and amortization.

The following table details the calculation of Total Gross Assets (in thousands):

	June 30, 2012			December 31, 2011			June 30, 2011
Consolidated total assets	$	17,789,768		$	17,408,475		$	17,693,058
Investments in and advances to unconsolidated joint ventures	(219,877		)	(224,052		)	(224,625		)
Accumulated depreciation and amortization	1,827,357			1,672,501			1,570,997
Accumulated depreciation and amortization from assets held for sale	—			1,705			7,114
Consolidated gross assets	$	19,397,248		$	18,858,629		$	19,046,544
HCP’s share of unconsolidated total assets(1)	267,782			269,606			297,427
HCP’s share of unconsolidated accumulated depreciation and amortization(1)	43,383			40,104			37,603
Total gross assets	$	19,708,413		$	19,168,339		$	19,381,574

(1) Reflects the Company’s pro rata share of amounts from the Investment Management Platform and its equity interest in HCR ManorCare OpCo.

Reporting Definitions and Reconciliations of Non-GAAP Measures

Total Market Capitalization. Total Debt plus Total Market Equity.

Total Market Equity. The total number of outstanding shares of the Company’s common stock multiplied by the closing price per share of its common stock on the New York Stock Exchange as of period end, plus the total number of convertible partnership units multiplied by the closing price per share of its common stock on the New York Stock Exchange as of period end (adjusted for stock splits), plus the total number of outstanding shares of the Company’s preferred stock multiplied by the closing price of its preferred stock on the New York Stock Exchange as of period end.

Total Secured Debt. Consolidated Secured Debt plus the Company’s pro rata share of mortgage debt from the Investment Management Platform.

Units/Square Feet/Beds. Senior housing facilities are measured in units (e.g., studio, one or two bedroom units). Life science facilities and medical office buildings are measured in square feet. Post-acute/skilled nursing facilities and hospitals are measured in licensed bed count.

Yield. Yield is calculated as Net Operating Income, as adjusted, divided by Investment. For acquisitions, initial yields are calculated as projected Net Operating Income, 12 months forward, as adjusted, as of the closing date divided by total acquisition cost basis. The total acquisition cost basis includes the initial purchase price, the effects of adjusting assumed debt to market, lease intangible adjustments and all transaction costs.

Attached files

HEALTHPEAK PROPERTIES, INC. Reports

Also read